Asahi Intecc | Evaluate

Smaller medtechs suffer, but not from Covid-19

Emergence from lockdown is the driving force behind many – but not all – of the small and mid-cap share price moves.

Mid cap device makers find rewards in cancer and diabetes

Investor excitement about smaller medtechs’ technology is unchecked, but these groups will have to deliver on their promises.

January 10, 2018

Smaller medtechs soar in ’17 but could now be too expensive

Many small groups are up thanks to takeover speculation, and this may end up being self-defeating.

January 09, 2017

A quiet year for mid-size medtech